–
Atara Biotherapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY22 to FY25
millions USD
FY21:
FY22:
63.6
FY23:
−0.31
FY24:
108
FY25:
99.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−340
FY22:
−281
FY23:
−276
FY24:
−83.4
FY25:
35.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
−331
FY22:
−273
FY23:
−266
FY24:
−75.7
FY25:
38.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−340
FY22:
−228
FY23:
−276
FY24:
−85.4
FY25:
32.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
−340
FY22:
−228
FY23:
−276
FY24:
−85.4
FY25:
32.7
All amounts in millions USD